Pfizer, BioNTech Beat US Rival's COVID Vaccine UPC Case
Pfizer and BioNTech have defeated a COVID-19 vaccine patent infringement claim from U.S. biotech firm Promosome, convincing the Unified Patent Court that the blueprint for immunization against the virus is invalid...To view the full article, register now.
Already a subscriber? Click here to view full article